Xavier Avat's Insider Trades & SAST Disclosures
Xavier Avat's most recent trade in Capricor Therapeutics Inc was a trade of 14,772 Common Stock done at an average price of $64258 . Disclosure was reported to the exchange on April 17, 2023.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Xavier Avat.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Capricor Therapeutics Inc | Xavier Avat | Former CBO | Sale of securities on an exchange or to another person at price $ 64258.00 per share. | 17 Apr 2023 | 14,772 | 0 (0%) | 0% | 64258 | 949,219,176 | Common Stock |
| Capricor Therapeutics Inc | Xavier Avat | FORMER CHIEF BUSINESS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.46 per share. | 28 Mar 2023 | 84,791 | 84,791 (1%) | 1% | 3.5 | 293,377 | Common Stock |
| Capricor Therapeutics Inc | Xavier Avat | FORMER CHIEF BUSINESS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Mar 2023 | 84,791 | 0 | - | - | Stock Option (Right to Buy) | |
| Capricor Therapeutics Inc | Xavier Avat | FORMER CHIEF BUSINESS OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.19 per share. | 28 Mar 2023 | 70,019 | 14,772 (0%) | 1% | 4.2 | 293,380 | Common Stock |
| Capricor Therapeutics Inc | Xavier Avat | FORMER CHIEF BUSINESS OFFICER | Sale of securities on an exchange or to another person at price $ 4.06 per share. | 28 Mar 2023 | 3,000 | 0 (0%) | 0% | 4.1 | 12,180 | Common Stock |
| Capricor Therapeutics Inc | Xavier Avat | CHIEF BUSINESS OFFICER | Purchase of securities on an exchange or from another person at price $ 3.76 per share. | 29 Jun 2022 | 1,500 | 2,000 (0%) | 0% | 3.8 | 5,643 | Common Stock |
| Capricor Therapeutics Inc | Xavier Avat | CHIEF BUSINESS OFFICER | Purchase of securities on an exchange or from another person at price $ 3.68 per share. | 29 Jun 2022 | 1,000 | 3,000 (0%) | 0% | 3.7 | 3,680 | Common Stock |
| Capricor Therapeutics Inc | Xavier Avat | CHIEF BUSINESS OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2022 | 370,000 | 370,000 | - | - | Stock Option (Right to Buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges